BIOLASE (NASDAQ:BIOL) Stock Price Crosses Above 200-Day Moving Average – Should You Sell?

Shares of BIOLASE, Inc. (NASDAQ:BIOLGet Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.01 and traded as high as $0.02. BIOLASE shares last traded at $0.01, with a volume of 35,749 shares changing hands.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of BIOLASE in a research note on Friday. They set a “sell” rating on the stock.

Get Our Latest Stock Report on BIOL

BIOLASE Stock Down 13.3 %

The firm has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.01. The stock has a market cap of $260,574.60, a P/E ratio of 0.00 and a beta of 0.67.

About BIOLASE

(Get Free Report)

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.

Featured Articles

Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.